Physician profile
Anthony Obeid
NPI 1720645286
$3,110.79
in general payments reported to CMS, 2019-2025
17 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $418 · 2023: $2,044 · 2024: $19.60 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,468 · Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,467.66 |
| Food and Beverage | $1,046.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,017.80 | 2022-2023 | Clareon |
| Regeneron Healthcare Solutions, INC. | $165.90 | 2025 | Eylea Hd |
| Astellas Pharma US INC | $132.63 | 2025 | Izervay |
| Biotissue Holdings INC. | $120.57 | 2021 | |
| Alimera Sciences, INC. | $119.07 | 2023 | Iluvien |
| Genentech, INC. | $118.01 | 2022 | |
| Glaukos Corporation | $91.61 | 2023 | |
| Catalyst Pharmaceuticals, INC. | $89.21 | 2025 | |
| Dutch Ophthalmic, USA | $69.87 | 2023 | Eva, Combined Machine, Tissueblue |
| Allergan, INC. | $46.43 | 2021 | |
| Genentech USA, INC. | $38.15 | 2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $24.78 | 2025 | Syfovre |
| Bausch & Lomb Americas INC. | $19.60 | 2024 | Stellaris |
| Stryker Corporation | $16.35 | 2022 | |
| Sight Sciences, INC. | $15.65 | 2023 | Omni Surgical System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.09 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Obeid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.